In last trading session, Blueprint Medicines Corp (NASDAQ:BPMC) saw 8.9 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price
Blueprint Medicines Corp (NASDAQ:BPMC) has a beta value of 0.84 and has seen 28.28 million shares traded in the recent trading session. The company, currently
Blueprint Medicines Corp (NASDAQ:BPMC)’s traded shares stood at 0.58 million during the latest session, with the company’s beta value hitting 0.83. At the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne